Recapitulation of metabolic defects in a model of propionic acidemia using patient-derived primary hepatocytes
Propionic acidemia (PA) is a disorder of intermediary metabolism with defects in the alpha or beta subunits of propionyl CoA carboxylase (PCCA and PCCB respectively) enzyme. We previously described a liver culture system that uses liver-derived hemodynamic blood flow and transport parameters to rest...
Uložené v:
| Vydané v: | Molecular genetics and metabolism Ročník 117; číslo 3; s. 355 - 362 |
|---|---|
| Hlavní autori: | , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
United States
Elsevier Inc
01.03.2016
|
| Predmet: | |
| ISSN: | 1096-7192, 1096-7206, 1096-7206 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Propionic acidemia (PA) is a disorder of intermediary metabolism with defects in the alpha or beta subunits of propionyl CoA carboxylase (PCCA and PCCB respectively) enzyme. We previously described a liver culture system that uses liver-derived hemodynamic blood flow and transport parameters to restore and maintain primary human hepatocyte biology and metabolism utilizing physiologically relevant milieu concentrations.
In this study, primary hepatocytes isolated from the explanted liver of an 8-year-old PA patient were cultured in the liver system for 10days and evaluated for retention of differentiated polarized morphology. The expression of PCCA and PCCB was assessed at a gene and protein level relative to healthy donor controls. Ammonia and urea levels were measured in the presence and absence of amino acid supplements to assess the metabolic consequences of branched-chain amino acid metabolism in this disease.
Primary hepatocytes from the PA patient maintained a differentiated polarized morphology (peripheral actin staining) over 10days of culture in the system. We noted lower levels of PCCA and PCCB relative to normal healthy controls at the mRNA and protein level. Supplementation of branched-chain amino acids, isoleucine (5mM) and valine (5mM) in the medium, resulted in increased ammonia and decreased urea in the PA patient hepatocyte system, but no such response was seen in healthy hepatocytes or patient-derived fibroblasts.
We demonstrate for the first time the successful culture of PA patient-derived primary hepatocytes in a differentiated state, that stably retain the PCCA and PCCB enzyme defects at a gene and protein level. Phenotypic response of the system to an increased load of branched-chain amino acids, not possible with fibroblasts, underscores the utility of this system in the better understanding of the molecular pathophysiology of PA and examining the effectiveness of potential therapeutic agents in the most relevant tissue.
•We describe an organotypic liver model for propionic acidemia using patient derived hepatocytes.•Hepatocytes in model retained differentiated morphology and function stably over 10days.•Molecular enzymatic defect was stably retained at gene and protein level.•Increased ammonia production by patient derived hepatocytes in response to amino acid loading in model•Similar responses not exhibited by healthy donor hepatocytes in model |
|---|---|
| AbstractList | Propionic acidemia (PA) is a disorder of intermediary metabolism with defects in the alpha or beta subunits of propionyl CoA carboxylase (PCCA and PCCB respectively) enzyme. We previously described a liver culture system that uses liver-derived hemodynamic blood flow and transport parameters to restore and maintain primary human hepatocyte biology and metabolism utilizing physiologically relevant milieu concentrations.
In this study, primary hepatocytes isolated from the explanted liver of an 8-year-old PA patient were cultured in the liver system for 10days and evaluated for retention of differentiated polarized morphology. The expression of PCCA and PCCB was assessed at a gene and protein level relative to healthy donor controls. Ammonia and urea levels were measured in the presence and absence of amino acid supplements to assess the metabolic consequences of branched-chain amino acid metabolism in this disease.
Primary hepatocytes from the PA patient maintained a differentiated polarized morphology (peripheral actin staining) over 10days of culture in the system. We noted lower levels of PCCA and PCCB relative to normal healthy controls at the mRNA and protein level. Supplementation of branched-chain amino acids, isoleucine (5mM) and valine (5mM) in the medium, resulted in increased ammonia and decreased urea in the PA patient hepatocyte system, but no such response was seen in healthy hepatocytes or patient-derived fibroblasts.
We demonstrate for the first time the successful culture of PA patient-derived primary hepatocytes in a differentiated state, that stably retain the PCCA and PCCB enzyme defects at a gene and protein level. Phenotypic response of the system to an increased load of branched-chain amino acids, not possible with fibroblasts, underscores the utility of this system in the better understanding of the molecular pathophysiology of PA and examining the effectiveness of potential therapeutic agents in the most relevant tissue.
•We describe an organotypic liver model for propionic acidemia using patient derived hepatocytes.•Hepatocytes in model retained differentiated morphology and function stably over 10days.•Molecular enzymatic defect was stably retained at gene and protein level.•Increased ammonia production by patient derived hepatocytes in response to amino acid loading in model•Similar responses not exhibited by healthy donor hepatocytes in model Propionic acidemia (PA) is a disorder of intermediary metabolism with defects in the alpha or beta subunits of propionyl CoA carboxylase (PCCA and PCCB respectively) enzyme. We previously described a liver culture system that uses liver-derived hemodynamic blood flow and transport parameters to restore and maintain primary human hepatocyte biology and metabolism utilizing physiologically relevant milieu concentrations. In this study, primary hepatocytes isolated from the explanted liver of an 8-year-old PA patient were cultured in the liver system for 10 days and evaluated for retention of differentiated polarized morphology. The expression of PCCA and PCCB was assessed at a gene and protein level relative to healthy donor controls. Ammonia and urea levels were measured in the presence and absence of amino acid supplements to assess the metabolic consequences of branched-chain amino acid metabolism in this disease. Primary hepatocytes from the PA patient maintained a differentiated polarized morphology (peripheral actin staining) over 10 days of culture in the system. We noted lower levels of PCCA and PCCB relative to normal healthy controls at the mRNA and protein level. Supplementation of branched-chain amino acids, isoleucine (5mM) and valine (5mM) in the medium, resulted in increased ammonia and decreased urea in the PA patient hepatocyte system, but no such response was seen in healthy hepatocytes or patient-derived fibroblasts. We demonstrate for the first time the successful culture of PA patient-derived primary hepatocytes in a differentiated state, that stably retain the PCCA and PCCB enzyme defects at a gene and protein level. Phenotypic response of the system to an increased load of branched-chain amino acids, not possible with fibroblasts, underscores the utility of this system in the better understanding of the molecular pathophysiology of PA and examining the effectiveness of potential therapeutic agents in the most relevant tissue. Propionic acidemia (PA) is a disorder of intermediary metabolism with defects in the alpha or beta subunits of propionyl CoA carboxylase (PCCA and PCCB respectively) enzyme. We previously described a liver culture system that uses liver-derived hemodynamic blood flow and transport parameters to restore and maintain primary human hepatocyte biology and metabolism utilizing physiologically relevant milieu concentrations.BACKGROUNDPropionic acidemia (PA) is a disorder of intermediary metabolism with defects in the alpha or beta subunits of propionyl CoA carboxylase (PCCA and PCCB respectively) enzyme. We previously described a liver culture system that uses liver-derived hemodynamic blood flow and transport parameters to restore and maintain primary human hepatocyte biology and metabolism utilizing physiologically relevant milieu concentrations.In this study, primary hepatocytes isolated from the explanted liver of an 8-year-old PA patient were cultured in the liver system for 10 days and evaluated for retention of differentiated polarized morphology. The expression of PCCA and PCCB was assessed at a gene and protein level relative to healthy donor controls. Ammonia and urea levels were measured in the presence and absence of amino acid supplements to assess the metabolic consequences of branched-chain amino acid metabolism in this disease.METHODSIn this study, primary hepatocytes isolated from the explanted liver of an 8-year-old PA patient were cultured in the liver system for 10 days and evaluated for retention of differentiated polarized morphology. The expression of PCCA and PCCB was assessed at a gene and protein level relative to healthy donor controls. Ammonia and urea levels were measured in the presence and absence of amino acid supplements to assess the metabolic consequences of branched-chain amino acid metabolism in this disease.Primary hepatocytes from the PA patient maintained a differentiated polarized morphology (peripheral actin staining) over 10 days of culture in the system. We noted lower levels of PCCA and PCCB relative to normal healthy controls at the mRNA and protein level. Supplementation of branched-chain amino acids, isoleucine (5mM) and valine (5mM) in the medium, resulted in increased ammonia and decreased urea in the PA patient hepatocyte system, but no such response was seen in healthy hepatocytes or patient-derived fibroblasts.RESULTSPrimary hepatocytes from the PA patient maintained a differentiated polarized morphology (peripheral actin staining) over 10 days of culture in the system. We noted lower levels of PCCA and PCCB relative to normal healthy controls at the mRNA and protein level. Supplementation of branched-chain amino acids, isoleucine (5mM) and valine (5mM) in the medium, resulted in increased ammonia and decreased urea in the PA patient hepatocyte system, but no such response was seen in healthy hepatocytes or patient-derived fibroblasts.We demonstrate for the first time the successful culture of PA patient-derived primary hepatocytes in a differentiated state, that stably retain the PCCA and PCCB enzyme defects at a gene and protein level. Phenotypic response of the system to an increased load of branched-chain amino acids, not possible with fibroblasts, underscores the utility of this system in the better understanding of the molecular pathophysiology of PA and examining the effectiveness of potential therapeutic agents in the most relevant tissue.CONCLUSIONSWe demonstrate for the first time the successful culture of PA patient-derived primary hepatocytes in a differentiated state, that stably retain the PCCA and PCCB enzyme defects at a gene and protein level. Phenotypic response of the system to an increased load of branched-chain amino acids, not possible with fibroblasts, underscores the utility of this system in the better understanding of the molecular pathophysiology of PA and examining the effectiveness of potential therapeutic agents in the most relevant tissue. Background: Propionic acidemia (PA) is a disorder of intermediary metabolism with defects in the alpha or beta subunits of propionyl CoA carboxylase (PCCA and PCCB respectively) enzyme. We previously described a liver culture system that uses liver-derived hemodynamic blood flow and transport parameters to restore and maintain primary human hepatocyte biology and metabolism utilizing physiologically relevant milieu concentrations. Methods: In this study, primary hepatocytes isolated from the explanted liver of an 8-year-old PA patient were cultured in the liver system for 10 days and evaluated for retention of differentiated polarized morphology. The expression of PCCA and PCCB was assessed at a gene and protein level relative to healthy donor controls. Ammonia and urea levels were measured in the presence and absence of amino acid supplements to assess the metabolic consequences of branched-chain amino acid metabolism in this disease. Results: Primary hepatocytes from the PA patient maintained a differentiated polarized morphology (peripheral actin staining) over 10 days of culture in the system. We noted lower levels of PCCA and PCCB relative to normal healthy controls at the mRNA and protein level. Supplementation of branched-chain amino acids, isoleucine (5 mM) and valine (5 mM) in the medium, resulted in increased ammonia and decreased urea in the PA patient hepatocyte system, but no such response was seen in healthy hepatocytes or patient-derived fibroblasts. Conclusions: We demonstrate for the first time the successful culture of PA patient-derived primary hepatocytes in a differentiated state, that stably retain the PCCA and PCCB enzyme defects at a gene and protein level. Phenotypic response of the system to an increased load of branched-chain amino acids, not possible with fibroblasts, underscores the utility of this system in the better understanding of the molecular pathophysiology of PA and examining the effectiveness of potential therapeutic agents in the most relevant tissue. |
| Author | Wamhoff, Brian R. Collado, Maria S. Purdy, Michael Simmers, Michael B. Summar, Marshall L. Cui, Wanxing Yazigi, Nada A. Hoang, Stephen A. Chapman, Kimberly A. Armstrong, Allison J. Dash, Ajit Figler, Robert A. |
| AuthorAffiliation | b Georgetown University Hospital, Washington, DC, United States c HemoShear Therapeutics, Charlottesville, VA, United States a Children’s National Medical Center and George Washington University, Washington, DC, United States d University of Virginia, Charlottesville, VA, United States |
| AuthorAffiliation_xml | – name: a Children’s National Medical Center and George Washington University, Washington, DC, United States – name: c HemoShear Therapeutics, Charlottesville, VA, United States – name: b Georgetown University Hospital, Washington, DC, United States – name: d University of Virginia, Charlottesville, VA, United States |
| Author_xml | – sequence: 1 givenname: Kimberly A. surname: Chapman fullname: Chapman, Kimberly A. organization: Children's National Medical Center and George Washington University, Washington, DC, United States – sequence: 2 givenname: Maria S. surname: Collado fullname: Collado, Maria S. organization: HemoShear Therapeutics, Charlottesville, VA, United States – sequence: 3 givenname: Robert A. surname: Figler fullname: Figler, Robert A. organization: HemoShear Therapeutics, Charlottesville, VA, United States – sequence: 4 givenname: Stephen A. surname: Hoang fullname: Hoang, Stephen A. organization: HemoShear Therapeutics, Charlottesville, VA, United States – sequence: 5 givenname: Allison J. surname: Armstrong fullname: Armstrong, Allison J. organization: HemoShear Therapeutics, Charlottesville, VA, United States – sequence: 6 givenname: Wanxing surname: Cui fullname: Cui, Wanxing organization: Georgetown University Hospital, Washington, DC, United States – sequence: 7 givenname: Michael surname: Purdy fullname: Purdy, Michael organization: University of Virginia, Charlottesville, VA, United States – sequence: 8 givenname: Michael B. surname: Simmers fullname: Simmers, Michael B. organization: HemoShear Therapeutics, Charlottesville, VA, United States – sequence: 9 givenname: Nada A. surname: Yazigi fullname: Yazigi, Nada A. organization: Georgetown University Hospital, Washington, DC, United States – sequence: 10 givenname: Marshall L. surname: Summar fullname: Summar, Marshall L. organization: Children's National Medical Center and George Washington University, Washington, DC, United States – sequence: 11 givenname: Brian R. surname: Wamhoff fullname: Wamhoff, Brian R. email: wamhoff@hemoshear.com organization: HemoShear Therapeutics, Charlottesville, VA, United States – sequence: 12 givenname: Ajit orcidid: 0000-0003-4033-4614 surname: Dash fullname: Dash, Ajit organization: HemoShear Therapeutics, Charlottesville, VA, United States |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26740382$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkctq3DAUhkVJaJJpn6BQtOzGri62bC9aKKE3CBRCuxby0fFEg225kj0wbx_NJaHtIilaSPBf-MV3Rc5GPyIhbzjLOePq_SbfDesBc8F4mXORM1a_IJecNSqrBFNnD2_eiAtyFeOGMc7LpnhJLoSqCiZrcUnGWwQzuXnpzez8SH1HB5xN63sH1GKHMEfqRmro4C32e30KfkrWpBtwFgdn6BLduKZTqsBxziwGt0WbjG4wYUfvMCkedjPGV-S8M33E16d7RX59-fzz-lt28-Pr9-tPNxmUvJqzyrSFACZ4bZTsoFBMGQ4tcK6UAGjb0nLWMSWtrISqJShZlIeDojQW5Yp8PPZOSzughTQrmF6fFmlvnP5bGd2dXvutLupSyKZIBe9OBcH_XjDOenARsO_NiH6JmlcNa4o0UP6HtRLJJpN3Rd7-OetxzwOPZJBHAwQfY8Du0cKZ3lPXG32grvfUNRc6UU-p5p8UuPnAM_3N9c9kPxyzmHBsHQYdIVEEtC4k-Np692T-HiFNy5U |
| CitedBy_id | crossref_primary_10_1016_j_ymgme_2021_03_001 crossref_primary_10_1371_journal_pone_0291330 crossref_primary_10_1016_j_scr_2020_101953 crossref_primary_10_1016_j_ymgme_2017_10_002 crossref_primary_10_1016_j_ymgme_2021_12_012 crossref_primary_10_1007_s12072_017_9838_6 crossref_primary_10_1016_j_ymgme_2020_05_003 crossref_primary_10_1002_ajmg_a_62893 crossref_primary_10_1038_s41598_021_84612_z crossref_primary_10_1038_s41598_023_40130_8 |
| Cites_doi | 10.1002/(SICI)1098-1004(199910)14:4<275::AID-HUMU1>3.0.CO;2-N 10.1002/ajmg.c.30090 10.1021/tx015518a 10.1016/0387-7604(94)90096-5 10.1038/nbt1361 10.1016/j.tox.2008.09.002 10.1093/toxsci/kfg064 10.1080/00498250210128675 10.1371/journal.pcbi.1000756 10.1113/expphysiol.1984.sp002829 10.1186/s13023-014-0130-8 10.1542/peds.2010-0008 10.1016/j.ymgme.2015.05.004 10.1016/j.ymgme.2011.09.022 10.1517/17425255.2.6.875 10.1016/0006-291X(66)90457-8 10.1016/0026-0495(88)90114-X 10.1038/nrd1345 10.1016/j.ymgme.2015.04.004 10.1016/j.cell.2014.05.010 10.1086/302971 10.1002/ajmg.a.35387 10.1016/j.bbadis.2013.04.027 10.1007/978-1-60761-688-7_3 10.1016/0006-291X(66)90456-6 10.1016/S0092-1157(85)80035-4 10.1038/srep02735 10.1016/j.ymgme.2011.08.034 10.1016/j.jhep.2014.10.016 10.1152/ajpcell.00331.2012 10.1093/jn/137.6.1626S 10.1016/S0925-4439(03)00039-5 10.1517/17425250903160664 10.1016/j.ymgme.2013.01.013 10.1172/JCI109614 10.1002/jcp.1041030304 10.1039/B913221J |
| ContentType | Journal Article |
| Copyright | 2015 Elsevier Inc. Copyright © 2015 Elsevier Inc. All rights reserved. |
| Copyright_xml | – notice: 2015 Elsevier Inc. – notice: Copyright © 2015 Elsevier Inc. All rights reserved. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 8FD FR3 P64 RC3 5PM |
| DOI | 10.1016/j.ymgme.2015.12.008 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Technology Research Database Engineering Research Database Biotechnology and BioEngineering Abstracts Genetics Abstracts PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic Genetics Abstracts Engineering Research Database Technology Research Database Biotechnology and BioEngineering Abstracts |
| DatabaseTitleList | MEDLINE MEDLINE - Academic Genetics Abstracts |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Anatomy & Physiology Chemistry Biology |
| EISSN | 1096-7206 |
| EndPage | 362 |
| ExternalDocumentID | PMC4852394 26740382 10_1016_j_ymgme_2015_12_008 S1096719215300925 |
| Genre | Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NIGMS NIH HHS grantid: R44 GM109539 – fundername: NIGMS NIH HHS grantid: R44GM109539 – fundername: NCATS NIH HHS grantid: R44 TR001407 – fundername: NIDDK NIH HHS grantid: DK105233 – fundername: NIDDK NIH HHS grantid: K08 DK105233 |
| GroupedDBID | --- --K --M -~X .55 .GJ .~1 0R~ 123 1B1 1RT 1~. 1~5 29M 4.4 457 4G. 53G 5RE 5VS 7-5 71M 8P~ AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AAXUO ABFNM ABFRF ABGSF ABJNI ABMAC ABUDA ABXDB ABYKQ ACDAQ ACGFO ACGFS ACRLP ADBBV ADEZE ADFGL ADMUD ADUVX AEBSH AEFWE AEHWI AEKER AENEX AFKWA AFTJW AFXIZ AGHFR AGRDE AGUBO AGYEJ AHPSJ AIEXJ AIKHN AITUG AJBFU AJOXV ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC CAG COF CS3 DM4 DOVZS DU5 EBS EFBJH EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-Q GBLVA HVGLF HZ~ IHE J1W K-O KOM L7B LG5 M41 MO0 N9A O-L O9- OAUVE OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SDF SDG SDP SES SEW SPCBC SSU SSZ T5K X7M XPP ZA5 ZGI ZMT ZU3 ~G- ~KM 9DU AATTM AAXKI AAYWO AAYXX ABWVN ACLOT ACRPL ACVFH ADCNI ADNMO AEIPS AEUPX AFJKZ AFPUW AGQPQ AIGII AIIUN AKBMS AKRWK AKYEP ANKPU APXCP CITATION EFKBS ~HD CGR CUY CVF ECM EIF NPM 7X8 8FD FR3 P64 RC3 5PM |
| ID | FETCH-LOGICAL-c517t-7ab42c0218a63fc4606a1cbc11662ccbb5d10f063d372683c634545454e25ade3 |
| ISICitedReferencesCount | 15 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000372683600158&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1096-7192 1096-7206 |
| IngestDate | Tue Sep 30 16:48:06 EDT 2025 Sun Sep 28 11:44:13 EDT 2025 Sun Sep 28 05:19:50 EDT 2025 Wed Feb 19 02:41:30 EST 2025 Tue Nov 18 20:00:23 EST 2025 Sat Nov 29 04:47:02 EST 2025 Fri Feb 23 02:30:30 EST 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Keywords | Ammonia Urea Organic acidemia Hepatocyte Propionic acidemia Hemodynamic flow |
| Language | English |
| License | Copyright © 2015 Elsevier Inc. All rights reserved. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c517t-7ab42c0218a63fc4606a1cbc11662ccbb5d10f063d372683c634545454e25ade3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0003-4033-4614 |
| PMID | 26740382 |
| PQID | 1772833318 |
| PQPubID | 23479 |
| PageCount | 8 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4852394 proquest_miscellaneous_1790942183 proquest_miscellaneous_1772833318 pubmed_primary_26740382 crossref_primary_10_1016_j_ymgme_2015_12_008 crossref_citationtrail_10_1016_j_ymgme_2015_12_008 elsevier_sciencedirect_doi_10_1016_j_ymgme_2015_12_008 |
| PublicationCentury | 2000 |
| PublicationDate | 2016-03-01 |
| PublicationDateYYYYMMDD | 2016-03-01 |
| PublicationDate_xml | – month: 03 year: 2016 text: 2016-03-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Molecular genetics and metabolism |
| PublicationTitleAlternate | Mol Genet Metab |
| PublicationYear | 2016 |
| Publisher | Elsevier Inc |
| Publisher_xml | – name: Elsevier Inc |
| References | Martignoni, Groothuis, de Kanter (bb0060) 2006; 2 Terelius, Figler, Marukian, Collado, Lawson, Mackey (bb0170) 2015 Dash, Simmers, Deering, Berry, Feaver, Hastings (bb0145) 2013; 304 Dash, Inman, Hoffmaster, Sevidal, Kelly, Obach (bb0140) 2009; 5 Vockley, Chapman, Arnold (bb0220) 2013; 108 Waterlow (bb0070) 1984; 69 Rodriguez-Antona, Donato, Boobis, Edwards, Watts, Castell (bb0125) 2002; 32 Lecluyse, Alexandre (bb0175) 2010; 640 Ayyub, Behrens, Heligman, Natoli, Ayoub, Cunningham (bb0190) 2015; 115 Boess, Kamber, Romer, Gasser, Muller, Albertini (bb0120) 2003; 73 Carrillo-Carrasco, Venditti (bb0010) 1993 Khetani, Bhatia (bb0130) 2008; 26 Dorsett, Tuschl (bb0195) 2004; 3 Hsu, Lander, Zhang (bb0200) 2014; 157 Ravn, Chloupkova, Christensen, Brandt, Simonsen, Kraus (bb0005) 2000; 67 Ball, Urschel, Pencharz (bb0065) 2007; 137 Kun, Volfin (bb0080) 1966; 23 Fenton, Gravel, Rosenblatt (bb0020) 2001 Pena, Franks, Chapman, Gropman, Ah Mew, Chakrapani (bb0040) 2012; 105 Berman, Tong, Williams (bb0110) 1980; 103 Varani, Dame, Rediske, Beals, Hillegas (bb0105) 1985; 13 Kolker, Valayannopoulos, Burlina, Sykut-Cegielska, Wijburg, Teles (bb0215) 2015 Perez-Cerda, Clavero, Perez, Rodriguez-Pombo, Desviat, Ugarte (bb0095) 2003; 1638 Ah, McCarter, Daikhin, Nissim, Yudkoff, Tuchman (bb0225) 2010; 126 Wambaugh, Shah (bb0185) 2010; 6 Pena, Burton (bb0035) 2012; 158A Dercksen, L IJ, Duran, Mienie, van Cruchten, van der Westhuizen (bb0230) 2014; 1842 Ugarte, Perez-Cerda, Rodriguez-Pombo, Desviat, Perez, Richard (bb0100) 1999; 14 Nelson, Treskes, Howie, Walker, Hayes, Plevris (bb0135) 2013; 3 Baker, Carfagna, Gao, Dow, Li, Searfoss (bb0115) 2001; 14 Chapman, Bush, Zhang (bb0210) 2015; 115 Coude, Sweetman, Nyhan (bb0025) 1979; 64 Baxter, Withey, Harrison, Segeritz, Zhang, Atkinson-Dell (bb0205) 2015; 62 Barash, Elpeleg, Amit, Gottfried, Yatziv, Gutman (bb0090) 1989; 25 Sutton, Chapman, Gropman, MacLeod, Stagni, Summar (bb0050) 2012; 105 Graham, Lake (bb0055) 2008; 254 Baumgartner, Horster, Dionisi-Vici, Haliloglu, Karall, Chapman (bb0045) 2014; 9 Kun, Loh, Volfin (bb0075) 1966; 23 Ozand, Rashed, Gascon, Youssef, Harfi, Rahbeeni (bb0015) 1994; 16 Cigolini, Bonora, Querena, Moghetti, Cacciatori, Zancanaro (bb0085) 1988; 37 Deodato, Boenzi, Santorelli, Dionisi-Vici (bb0030) 2006; 142C Domansky, Inman, Serdy, Dash, Lim, Griffith (bb0150) 2010; 10 (bb0160) 2013 (bb0155) 2013 (bb0165) 2012 Maass-Moreno, Rothe (bb0180) 1997; 272 Ozand (10.1016/j.ymgme.2015.12.008_bb0015) 1994; 16 Wambaugh (10.1016/j.ymgme.2015.12.008_bb0185) 2010; 6 Varani (10.1016/j.ymgme.2015.12.008_bb0105) 1985; 13 Berman (10.1016/j.ymgme.2015.12.008_bb0110) 1980; 103 Carrillo-Carrasco (10.1016/j.ymgme.2015.12.008_bb0010) 1993 Graham (10.1016/j.ymgme.2015.12.008_bb0055) 2008; 254 (10.1016/j.ymgme.2015.12.008_bb0160) 2013 Kun (10.1016/j.ymgme.2015.12.008_bb0080) 1966; 23 (10.1016/j.ymgme.2015.12.008_bb0155) 2013 (10.1016/j.ymgme.2015.12.008_bb0165) 2012 Hsu (10.1016/j.ymgme.2015.12.008_bb0200) 2014; 157 Khetani (10.1016/j.ymgme.2015.12.008_bb0130) 2008; 26 Ayyub (10.1016/j.ymgme.2015.12.008_bb0190) 2015; 115 Coude (10.1016/j.ymgme.2015.12.008_bb0025) 1979; 64 Nelson (10.1016/j.ymgme.2015.12.008_bb0135) 2013; 3 Pena (10.1016/j.ymgme.2015.12.008_bb0040) 2012; 105 Baumgartner (10.1016/j.ymgme.2015.12.008_bb0045) 2014; 9 Deodato (10.1016/j.ymgme.2015.12.008_bb0030) 2006; 142C Terelius (10.1016/j.ymgme.2015.12.008_bb0170) 2015 Fenton (10.1016/j.ymgme.2015.12.008_bb0020) 2001 Dash (10.1016/j.ymgme.2015.12.008_bb0140) 2009; 5 Dercksen (10.1016/j.ymgme.2015.12.008_bb0230) 2014; 1842 Kun (10.1016/j.ymgme.2015.12.008_bb0075) 1966; 23 Dash (10.1016/j.ymgme.2015.12.008_bb0145) 2013; 304 Waterlow (10.1016/j.ymgme.2015.12.008_bb0070) 1984; 69 Baxter (10.1016/j.ymgme.2015.12.008_bb0205) 2015; 62 Chapman (10.1016/j.ymgme.2015.12.008_bb0210) 2015; 115 Sutton (10.1016/j.ymgme.2015.12.008_bb0050) 2012; 105 Cigolini (10.1016/j.ymgme.2015.12.008_bb0085) 1988; 37 Kolker (10.1016/j.ymgme.2015.12.008_bb0215) 2015 Ugarte (10.1016/j.ymgme.2015.12.008_bb0100) 1999; 14 Barash (10.1016/j.ymgme.2015.12.008_bb0090) 1989; 25 Vockley (10.1016/j.ymgme.2015.12.008_bb0220) 2013; 108 Boess (10.1016/j.ymgme.2015.12.008_bb0120) 2003; 73 Ravn (10.1016/j.ymgme.2015.12.008_bb0005) 2000; 67 Pena (10.1016/j.ymgme.2015.12.008_bb0035) 2012; 158A Perez-Cerda (10.1016/j.ymgme.2015.12.008_bb0095) 2003; 1638 Ball (10.1016/j.ymgme.2015.12.008_bb0065) 2007; 137 Dorsett (10.1016/j.ymgme.2015.12.008_bb0195) 2004; 3 Martignoni (10.1016/j.ymgme.2015.12.008_bb0060) 2006; 2 Baker (10.1016/j.ymgme.2015.12.008_bb0115) 2001; 14 Ah (10.1016/j.ymgme.2015.12.008_bb0225) 2010; 126 Lecluyse (10.1016/j.ymgme.2015.12.008_bb0175) 2010; 640 Domansky (10.1016/j.ymgme.2015.12.008_bb0150) 2010; 10 Rodriguez-Antona (10.1016/j.ymgme.2015.12.008_bb0125) 2002; 32 Maass-Moreno (10.1016/j.ymgme.2015.12.008_bb0180) 1997; 272 5963894 - Biochem Biophys Res Commun. 1966 Jun 13;23(5):696-701 19637986 - Expert Opin Drug Metab Toxicol. 2009 Oct;5(10):1159-74 17513439 - J Nutr. 2007 Jun;137(6 Suppl 2):1626S-1641S 23428739 - Mol Genet Metab. 2013 Apr;108(4):203-5 25205257 - Orphanet J Rare Dis. 2014;9:130 10820128 - Am J Hum Genet. 2000 Jul;67(1):203-6 22678880 - Am J Med Genet A. 2012 Jul;158A(7):1641-6 25936660 - Mol Genet Metab. 2015 Jun-Jul;115(2-3):95-100 25963861 - Mol Genet Metab. 2015 Aug;115(4):174-9 4381469 - Biochem Biophys Res Commun. 1966 Jun 13;23(5):702-6 7726381 - Brain Dev. 1994 Nov;16 Suppl:46-57 21986446 - Mol Genet Metab. 2012 Jan;105(1):5-9 23643712 - Biochim Biophys Acta. 2014 Dec;1842(12 Pt A):2510-6 16602092 - Am J Med Genet C Semin Med Genet. 2006 May 15;142C(2):104-12 6382379 - Q J Exp Physiol. 1984 Jul;69(3):409-38 6249828 - J Cell Physiol. 1980 Jun;103(3):393-8 20566609 - Pediatrics. 2010 Jul;126(1):e208-14 18824059 - Toxicology. 2008 Dec 30;254(3):184-91 15060527 - Nat Rev Drug Discov. 2004 Apr;3(4):318-29 26626330 - Chem Biol Interact. 2016 Aug 5;255 :31-44 12160483 - Xenobiotica. 2002 Jun;32(6):505-20 18026090 - Nat Biotechnol. 2008 Jan;26(1):120-6 12657743 - Toxicol Sci. 2003 Jun;73(2):386-402 24906146 - Cell. 2014 Jun 5;157(6):1262-78 24061220 - Sci Rep. 2013;3:2735 3419322 - Metabolism. 1988 Sep;37(9):820-3 2495260 - Isr J Med Sci. 1989 Feb;25(2):103-6 21963082 - Mol Genet Metab. 2012 Jan;105(1):26-33 20024050 - Lab Chip. 2010 Jan 7;10(1):51-8 9227562 - Am J Physiol. 1997 Jun;272(6 Pt 2):H2826-32 20645046 - Methods Mol Biol. 2010;640:57-82 11559036 - Chem Res Toxicol. 2001 Sep;14(9):1218-31 25457200 - J Hepatol. 2015 Mar;62(3):581-9 25875216 - J Inherit Metab Dis. 2015 Nov;38(6):1059-74 20421935 - PLoS Comput Biol. 2010 Apr;6(4):e1000756 23485712 - Am J Physiol Cell Physiol. 2013 Jun 1;304(11):C1053-63 2985616 - J Biol Stand. 1985 Jan;13(1):67-76 17125407 - Expert Opin Drug Metab Toxicol. 2006 Dec;2(6):875-94 12757933 - Biochim Biophys Acta. 2003 May 20;1638(1):43-9 10502773 - Hum Mutat. 1999;14(4):275-82 500823 - J Clin Invest. 1979 Dec;64(6):1544-51 |
| References_xml | – volume: 23 start-page: 702 year: 1966 end-page: 706 ident: bb0075 article-title: Tissue specific differences in rate limiting factors of glutamate metabolism in enzyme systems of kidney and liver publication-title: Biochem. Biophys. Res. Commun. – volume: 1638 start-page: 43 year: 2003 end-page: 49 ident: bb0095 article-title: Functional analysis of PCCB mutations causing propionic acidemia based on expression studies in deficient human skin fibroblasts publication-title: Biochim. Biophys. Acta – volume: 69 start-page: 409 year: 1984 end-page: 438 ident: bb0070 article-title: Protein turnover with special reference to man publication-title: Q. J. Exp. Physiol. – volume: 304 start-page: C1053 year: 2013 end-page: C1063 ident: bb0145 article-title: Hemodynamic flow improves rat hepatocyte morphology, function, and metabolic activity in vitro publication-title: Am. J. Physiol. Cell Physiol. – volume: 10 start-page: 51 year: 2010 end-page: 58 ident: bb0150 article-title: Perfused multiwell plate for 3D liver tissue engineering publication-title: Lab Chip – volume: 272 start-page: H2826 year: 1997 end-page: H2832 ident: bb0180 article-title: Distribution of pressure gradients along hepatic vasculature publication-title: Am. J. Phys. – volume: 13 start-page: 67 year: 1985 end-page: 76 ident: bb0105 article-title: Substrate-dependent differences in growth and biological properties of fibroblasts and epithelial cells grown in microcarrier culture publication-title: J. Biol. Stand. – volume: 14 start-page: 1218 year: 2001 end-page: 1231 ident: bb0115 article-title: Temporal gene expression analysis of monolayer cultured rat hepatocytes publication-title: Chem. Res. Toxicol. – year: 2013 ident: bb0160 publication-title: Physiological Hemodynamics And Transport Restore Insulin and Glucagon Responses in a Normal Glucose Milieu in Hepatocytes In Vitro. 73rd Scientific Sessions of the American Diabetes Association – volume: 157 start-page: 1262 year: 2014 end-page: 1278 ident: bb0200 article-title: Development and applications of CRISPR-Cas9 for genome engineering publication-title: Cell – year: 2015 ident: bb0170 article-title: Transcriptional profiling suggests that nevirapine and ritonavir cause drug induced liver injury through distinct mechanisms in primary human hepatocytes publication-title: Chem. Biol. Interact. – volume: 115 start-page: 95 year: 2015 end-page: 100 ident: bb0190 article-title: Simple and inexpensive quantification of ammonia in whole blood publication-title: Mol. Genet. Metab. – volume: 105 start-page: 26 year: 2012 end-page: 33 ident: bb0050 article-title: Chronic management and health supervision of individuals with propionic acidemia publication-title: Mol. Genet. Metab. – year: 2015 ident: bb0215 article-title: The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 2: the evolving clinical phenotype publication-title: J. Inherit. Metab. Dis. – volume: 2 start-page: 875 year: 2006 end-page: 894 ident: bb0060 article-title: Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction publication-title: Expert Opin. Drug Metab. Toxicol. – volume: 254 start-page: 184 year: 2008 end-page: 191 ident: bb0055 article-title: Induction of drug metabolism: species differences and toxicological relevance publication-title: Toxicology – volume: 126 start-page: e208 year: 2010 end-page: e214 ident: bb0225 article-title: N-carbamylglutamate augments ureagenesis and reduces ammonia and glutamine in propionic acidemia publication-title: Pediatrics – volume: 16 start-page: 46 year: 1994 end-page: 57 ident: bb0015 article-title: Unusual presentations of propionic acidemia publication-title: Brain Dev. – volume: 105 start-page: 5 year: 2012 end-page: 9 ident: bb0040 article-title: Natural history of propionic acidemia publication-title: Mol. Genet. Metab. – volume: 137 start-page: 1626S year: 2007 end-page: 1641S ident: bb0065 article-title: Nutritional consequences of interspecies differences in arginine and lysine metabolism publication-title: J. Nutr. – volume: 1842 start-page: 2510 year: 2014 end-page: 2516 ident: bb0230 article-title: Inhibition of N-acetylglutamate synthase by various monocarboxylic and dicarboxylic short-chain coenzyme A esters and the production of alternative glutamate esters publication-title: Biochim. Biophys. Acta – year: 1993 ident: bb0010 article-title: Propionic acidemia publication-title: GeneReviews(R) – year: 2012 ident: bb0165 publication-title: Development of an In-vitro Model of Hepatic Steatosis Using Rat Hepatocytes Under Controlled Hemodynamics in a Diabetic Milieu – volume: 23 start-page: 696 year: 1966 end-page: 701 ident: bb0080 article-title: Metabolic differences between mitochondria isolated from various tissues publication-title: Biochem. Biophys. Res. Commun. – volume: 3 start-page: 2735 year: 2013 ident: bb0135 article-title: Profiling the impact of medium formulation on morphology and functionality of primary hepatocytes in vitro publication-title: Sci. Rep. – volume: 25 start-page: 103 year: 1989 end-page: 106 ident: bb0090 article-title: Propionic acidemia—biochemical studies publication-title: Isr. J. Med. Sci. – volume: 9 start-page: 130 year: 2014 ident: bb0045 article-title: Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia publication-title: Orphanet J. Rare Dis. – volume: 5 start-page: 1159 year: 2009 end-page: 1174 ident: bb0140 article-title: Liver tissue engineering in the evaluation of drug safety publication-title: Expert Opin. Drug Metab. Toxicol. – volume: 6 year: 2010 ident: bb0185 article-title: Simulating microdosimetry in a virtual hepatic lobule publication-title: PLoS Comput. Biol. – volume: 103 start-page: 393 year: 1980 end-page: 398 ident: bb0110 article-title: Differences between rat liver epithelial and fibroblast cells in metabolism of purines publication-title: J. Cell. Physiol. – volume: 108 start-page: 203 year: 2013 end-page: 205 ident: bb0220 article-title: Development of clinical guidelines for inborn errors of metabolism: commentary publication-title: Mol. Genet. Metab. – volume: 26 start-page: 120 year: 2008 end-page: 126 ident: bb0130 article-title: Microscale culture of human liver cells for drug development publication-title: Nat. Biotechnol. – volume: 142C start-page: 104 year: 2006 end-page: 112 ident: bb0030 article-title: Methylmalonic and propionic aciduria publication-title: Am. J. Med. Genet. C: Semin. Med. Genet. – volume: 14 start-page: 275 year: 1999 end-page: 282 ident: bb0100 article-title: Overview of mutations in the PCCA and PCCB genes causing propionic acidemia publication-title: Hum. Mutat. – year: 2013 ident: bb0155 publication-title: Human Primary Hepatocytes Under Controlled Hemodynamics Elicit Induction Responses to Drugs at Clinical Cmax Concentrations. 52nd Annual Meeting of the Society of Toxicology – volume: 64 start-page: 1544 year: 1979 end-page: 1551 ident: bb0025 article-title: Inhibition by propionyl-coenzyme A of N-acetylglutamate synthetase in rat liver mitochondria. A possible explanation for hyperammonemia in propionic and methylmalonic acidemia publication-title: J. Clin. Invest. – volume: 73 start-page: 386 year: 2003 end-page: 402 ident: bb0120 article-title: Gene expression in two hepatic cell lines, cultured primary hepatocytes, and liver slices compared to the in vivo liver gene expression in rats: possible implications for toxicogenomics use of in vitro systems publication-title: Toxicol. Sci. – volume: 640 start-page: 57 year: 2010 end-page: 82 ident: bb0175 article-title: Isolation and culture of primary hepatocytes from resected human liver tissue publication-title: Methods Mol. Biol. – volume: 62 start-page: 581 year: 2015 end-page: 589 ident: bb0205 article-title: Phenotypic and functional analyses show stem cell-derived hepatocyte-like cells better mimic fetal rather than adult hepatocytes publication-title: J. Hepatol. – start-page: 2165 year: 2001 end-page: 2193 ident: bb0020 article-title: Disorders of propionate and methylmalonate metabolism publication-title: The Metabolic & Molecular Basis of Inherited Disease – volume: 32 start-page: 505 year: 2002 end-page: 520 ident: bb0125 article-title: Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: molecular mechanisms that determine lower expression in cultured cells publication-title: Xenobiotica – volume: 3 start-page: 318 year: 2004 end-page: 329 ident: bb0195 article-title: siRNAs: applications in functional genomics and potential as therapeutics publication-title: Nat. Rev. Drug Discov. – volume: 115 start-page: 174 year: 2015 end-page: 179 ident: bb0210 article-title: Gene expression in cell lines from propionic acidemia patients, carrier parents, and controls publication-title: Mol. Genet. Metab. – volume: 37 start-page: 820 year: 1988 end-page: 823 ident: bb0085 article-title: Differences in glucose metabolic enzyme activities in human adipose tissue from abdominal and gluteal regions publication-title: Metabolism – volume: 158A start-page: 1641 year: 2012 end-page: 1646 ident: bb0035 article-title: Survey of health status and complications among propionic acidemia patients publication-title: Am. J. Med. Genet. A – volume: 67 start-page: 203 year: 2000 end-page: 206 ident: bb0005 article-title: High incidence of propionic acidemia in greenland is due to a prevalent mutation, 1540insCCC, in the gene for the beta-subunit of propionyl CoA carboxylase publication-title: Am. J. Hum. Genet. – volume: 14 start-page: 275 issue: 4 year: 1999 ident: 10.1016/j.ymgme.2015.12.008_bb0100 article-title: Overview of mutations in the PCCA and PCCB genes causing propionic acidemia publication-title: Hum. Mutat. doi: 10.1002/(SICI)1098-1004(199910)14:4<275::AID-HUMU1>3.0.CO;2-N – volume: 142C start-page: 104 issue: 2 year: 2006 ident: 10.1016/j.ymgme.2015.12.008_bb0030 article-title: Methylmalonic and propionic aciduria publication-title: Am. J. Med. Genet. C: Semin. Med. Genet. doi: 10.1002/ajmg.c.30090 – volume: 14 start-page: 1218 issue: 9 year: 2001 ident: 10.1016/j.ymgme.2015.12.008_bb0115 article-title: Temporal gene expression analysis of monolayer cultured rat hepatocytes publication-title: Chem. Res. Toxicol. doi: 10.1021/tx015518a – volume: 16 start-page: 46 issue: Suppl year: 1994 ident: 10.1016/j.ymgme.2015.12.008_bb0015 article-title: Unusual presentations of propionic acidemia publication-title: Brain Dev. doi: 10.1016/0387-7604(94)90096-5 – volume: 26 start-page: 120 issue: 1 year: 2008 ident: 10.1016/j.ymgme.2015.12.008_bb0130 article-title: Microscale culture of human liver cells for drug development publication-title: Nat. Biotechnol. doi: 10.1038/nbt1361 – volume: 254 start-page: 184 issue: 3 year: 2008 ident: 10.1016/j.ymgme.2015.12.008_bb0055 article-title: Induction of drug metabolism: species differences and toxicological relevance publication-title: Toxicology doi: 10.1016/j.tox.2008.09.002 – volume: 73 start-page: 386 issue: 2 year: 2003 ident: 10.1016/j.ymgme.2015.12.008_bb0120 article-title: Gene expression in two hepatic cell lines, cultured primary hepatocytes, and liver slices compared to the in vivo liver gene expression in rats: possible implications for toxicogenomics use of in vitro systems publication-title: Toxicol. Sci. doi: 10.1093/toxsci/kfg064 – volume: 32 start-page: 505 issue: 6 year: 2002 ident: 10.1016/j.ymgme.2015.12.008_bb0125 article-title: Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: molecular mechanisms that determine lower expression in cultured cells publication-title: Xenobiotica doi: 10.1080/00498250210128675 – volume: 25 start-page: 103 issue: 2 year: 1989 ident: 10.1016/j.ymgme.2015.12.008_bb0090 article-title: Propionic acidemia—biochemical studies publication-title: Isr. J. Med. Sci. – volume: 6 issue: 4 year: 2010 ident: 10.1016/j.ymgme.2015.12.008_bb0185 article-title: Simulating microdosimetry in a virtual hepatic lobule publication-title: PLoS Comput. Biol. doi: 10.1371/journal.pcbi.1000756 – volume: 69 start-page: 409 issue: 3 year: 1984 ident: 10.1016/j.ymgme.2015.12.008_bb0070 article-title: Protein turnover with special reference to man publication-title: Q. J. Exp. Physiol. doi: 10.1113/expphysiol.1984.sp002829 – volume: 9 start-page: 130 year: 2014 ident: 10.1016/j.ymgme.2015.12.008_bb0045 article-title: Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia publication-title: Orphanet J. Rare Dis. doi: 10.1186/s13023-014-0130-8 – volume: 126 start-page: e208 issue: 1 year: 2010 ident: 10.1016/j.ymgme.2015.12.008_bb0225 article-title: N-carbamylglutamate augments ureagenesis and reduces ammonia and glutamine in propionic acidemia publication-title: Pediatrics doi: 10.1542/peds.2010-0008 – start-page: 2165 year: 2001 ident: 10.1016/j.ymgme.2015.12.008_bb0020 article-title: Disorders of propionate and methylmalonate metabolism – volume: 115 start-page: 174 issue: 4 year: 2015 ident: 10.1016/j.ymgme.2015.12.008_bb0210 article-title: Gene expression in cell lines from propionic acidemia patients, carrier parents, and controls publication-title: Mol. Genet. Metab. doi: 10.1016/j.ymgme.2015.05.004 – year: 2015 ident: 10.1016/j.ymgme.2015.12.008_bb0170 article-title: Transcriptional profiling suggests that nevirapine and ritonavir cause drug induced liver injury through distinct mechanisms in primary human hepatocytes publication-title: Chem. Biol. Interact. – year: 1993 ident: 10.1016/j.ymgme.2015.12.008_bb0010 article-title: Propionic acidemia – volume: 105 start-page: 5 issue: 1 year: 2012 ident: 10.1016/j.ymgme.2015.12.008_bb0040 article-title: Natural history of propionic acidemia publication-title: Mol. Genet. Metab. doi: 10.1016/j.ymgme.2011.09.022 – volume: 2 start-page: 875 issue: 6 year: 2006 ident: 10.1016/j.ymgme.2015.12.008_bb0060 article-title: Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction publication-title: Expert Opin. Drug Metab. Toxicol. doi: 10.1517/17425255.2.6.875 – year: 2013 ident: 10.1016/j.ymgme.2015.12.008_bb0160 – volume: 23 start-page: 702 issue: 5 year: 1966 ident: 10.1016/j.ymgme.2015.12.008_bb0075 article-title: Tissue specific differences in rate limiting factors of glutamate metabolism in enzyme systems of kidney and liver publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/0006-291X(66)90457-8 – volume: 37 start-page: 820 issue: 9 year: 1988 ident: 10.1016/j.ymgme.2015.12.008_bb0085 article-title: Differences in glucose metabolic enzyme activities in human adipose tissue from abdominal and gluteal regions publication-title: Metabolism doi: 10.1016/0026-0495(88)90114-X – year: 2013 ident: 10.1016/j.ymgme.2015.12.008_bb0155 – volume: 3 start-page: 318 issue: 4 year: 2004 ident: 10.1016/j.ymgme.2015.12.008_bb0195 article-title: siRNAs: applications in functional genomics and potential as therapeutics publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd1345 – volume: 115 start-page: 95 issue: 2–3 year: 2015 ident: 10.1016/j.ymgme.2015.12.008_bb0190 article-title: Simple and inexpensive quantification of ammonia in whole blood publication-title: Mol. Genet. Metab. doi: 10.1016/j.ymgme.2015.04.004 – volume: 157 start-page: 1262 issue: 6 year: 2014 ident: 10.1016/j.ymgme.2015.12.008_bb0200 article-title: Development and applications of CRISPR-Cas9 for genome engineering publication-title: Cell doi: 10.1016/j.cell.2014.05.010 – volume: 67 start-page: 203 issue: 1 year: 2000 ident: 10.1016/j.ymgme.2015.12.008_bb0005 article-title: High incidence of propionic acidemia in greenland is due to a prevalent mutation, 1540insCCC, in the gene for the beta-subunit of propionyl CoA carboxylase publication-title: Am. J. Hum. Genet. doi: 10.1086/302971 – volume: 158A start-page: 1641 year: 2012 ident: 10.1016/j.ymgme.2015.12.008_bb0035 article-title: Survey of health status and complications among propionic acidemia patients publication-title: Am. J. Med. Genet. A doi: 10.1002/ajmg.a.35387 – volume: 1842 start-page: 2510 issue: 12 Pt A year: 2014 ident: 10.1016/j.ymgme.2015.12.008_bb0230 article-title: Inhibition of N-acetylglutamate synthase by various monocarboxylic and dicarboxylic short-chain coenzyme A esters and the production of alternative glutamate esters publication-title: Biochim. Biophys. Acta doi: 10.1016/j.bbadis.2013.04.027 – year: 2015 ident: 10.1016/j.ymgme.2015.12.008_bb0215 article-title: The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 2: the evolving clinical phenotype publication-title: J. Inherit. Metab. Dis. – volume: 640 start-page: 57 year: 2010 ident: 10.1016/j.ymgme.2015.12.008_bb0175 article-title: Isolation and culture of primary hepatocytes from resected human liver tissue publication-title: Methods Mol. Biol. doi: 10.1007/978-1-60761-688-7_3 – volume: 23 start-page: 696 issue: 5 year: 1966 ident: 10.1016/j.ymgme.2015.12.008_bb0080 article-title: Metabolic differences between mitochondria isolated from various tissues publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/0006-291X(66)90456-6 – year: 2012 ident: 10.1016/j.ymgme.2015.12.008_bb0165 – volume: 13 start-page: 67 issue: 1 year: 1985 ident: 10.1016/j.ymgme.2015.12.008_bb0105 article-title: Substrate-dependent differences in growth and biological properties of fibroblasts and epithelial cells grown in microcarrier culture publication-title: J. Biol. Stand. doi: 10.1016/S0092-1157(85)80035-4 – volume: 3 start-page: 2735 year: 2013 ident: 10.1016/j.ymgme.2015.12.008_bb0135 article-title: Profiling the impact of medium formulation on morphology and functionality of primary hepatocytes in vitro publication-title: Sci. Rep. doi: 10.1038/srep02735 – volume: 105 start-page: 26 issue: 1 year: 2012 ident: 10.1016/j.ymgme.2015.12.008_bb0050 article-title: Chronic management and health supervision of individuals with propionic acidemia publication-title: Mol. Genet. Metab. doi: 10.1016/j.ymgme.2011.08.034 – volume: 62 start-page: 581 issue: 3 year: 2015 ident: 10.1016/j.ymgme.2015.12.008_bb0205 article-title: Phenotypic and functional analyses show stem cell-derived hepatocyte-like cells better mimic fetal rather than adult hepatocytes publication-title: J. Hepatol. doi: 10.1016/j.jhep.2014.10.016 – volume: 304 start-page: C1053 issue: 11 year: 2013 ident: 10.1016/j.ymgme.2015.12.008_bb0145 article-title: Hemodynamic flow improves rat hepatocyte morphology, function, and metabolic activity in vitro publication-title: Am. J. Physiol. Cell Physiol. doi: 10.1152/ajpcell.00331.2012 – volume: 272 start-page: H2826 issue: 6 Pt 2 year: 1997 ident: 10.1016/j.ymgme.2015.12.008_bb0180 article-title: Distribution of pressure gradients along hepatic vasculature publication-title: Am. J. Phys. – volume: 137 start-page: 1626S issue: 6 Suppl. 2 year: 2007 ident: 10.1016/j.ymgme.2015.12.008_bb0065 article-title: Nutritional consequences of interspecies differences in arginine and lysine metabolism publication-title: J. Nutr. doi: 10.1093/jn/137.6.1626S – volume: 1638 start-page: 43 issue: 1 year: 2003 ident: 10.1016/j.ymgme.2015.12.008_bb0095 article-title: Functional analysis of PCCB mutations causing propionic acidemia based on expression studies in deficient human skin fibroblasts publication-title: Biochim. Biophys. Acta doi: 10.1016/S0925-4439(03)00039-5 – volume: 5 start-page: 1159 issue: 10 year: 2009 ident: 10.1016/j.ymgme.2015.12.008_bb0140 article-title: Liver tissue engineering in the evaluation of drug safety publication-title: Expert Opin. Drug Metab. Toxicol. doi: 10.1517/17425250903160664 – volume: 108 start-page: 203 issue: 4 year: 2013 ident: 10.1016/j.ymgme.2015.12.008_bb0220 article-title: Development of clinical guidelines for inborn errors of metabolism: commentary publication-title: Mol. Genet. Metab. doi: 10.1016/j.ymgme.2013.01.013 – volume: 64 start-page: 1544 issue: 6 year: 1979 ident: 10.1016/j.ymgme.2015.12.008_bb0025 article-title: Inhibition by propionyl-coenzyme A of N-acetylglutamate synthetase in rat liver mitochondria. A possible explanation for hyperammonemia in propionic and methylmalonic acidemia publication-title: J. Clin. Invest. doi: 10.1172/JCI109614 – volume: 103 start-page: 393 issue: 3 year: 1980 ident: 10.1016/j.ymgme.2015.12.008_bb0110 article-title: Differences between rat liver epithelial and fibroblast cells in metabolism of purines publication-title: J. Cell. Physiol. doi: 10.1002/jcp.1041030304 – volume: 10 start-page: 51 issue: 1 year: 2010 ident: 10.1016/j.ymgme.2015.12.008_bb0150 article-title: Perfused multiwell plate for 3D liver tissue engineering publication-title: Lab Chip doi: 10.1039/B913221J – reference: 25205257 - Orphanet J Rare Dis. 2014;9:130 – reference: 20645046 - Methods Mol Biol. 2010;640:57-82 – reference: 25936660 - Mol Genet Metab. 2015 Jun-Jul;115(2-3):95-100 – reference: 20024050 - Lab Chip. 2010 Jan 7;10(1):51-8 – reference: 25875216 - J Inherit Metab Dis. 2015 Nov;38(6):1059-74 – reference: 9227562 - Am J Physiol. 1997 Jun;272(6 Pt 2):H2826-32 – reference: 23485712 - Am J Physiol Cell Physiol. 2013 Jun 1;304(11):C1053-63 – reference: 23643712 - Biochim Biophys Acta. 2014 Dec;1842(12 Pt A):2510-6 – reference: 17125407 - Expert Opin Drug Metab Toxicol. 2006 Dec;2(6):875-94 – reference: 6249828 - J Cell Physiol. 1980 Jun;103(3):393-8 – reference: 12160483 - Xenobiotica. 2002 Jun;32(6):505-20 – reference: 12657743 - Toxicol Sci. 2003 Jun;73(2):386-402 – reference: 18824059 - Toxicology. 2008 Dec 30;254(3):184-91 – reference: 4381469 - Biochem Biophys Res Commun. 1966 Jun 13;23(5):702-6 – reference: 3419322 - Metabolism. 1988 Sep;37(9):820-3 – reference: 10820128 - Am J Hum Genet. 2000 Jul;67(1):203-6 – reference: 24061220 - Sci Rep. 2013;3:2735 – reference: 21986446 - Mol Genet Metab. 2012 Jan;105(1):5-9 – reference: 20566609 - Pediatrics. 2010 Jul;126(1):e208-14 – reference: 24906146 - Cell. 2014 Jun 5;157(6):1262-78 – reference: 10502773 - Hum Mutat. 1999;14(4):275-82 – reference: 500823 - J Clin Invest. 1979 Dec;64(6):1544-51 – reference: 17513439 - J Nutr. 2007 Jun;137(6 Suppl 2):1626S-1641S – reference: 18026090 - Nat Biotechnol. 2008 Jan;26(1):120-6 – reference: 6382379 - Q J Exp Physiol. 1984 Jul;69(3):409-38 – reference: 15060527 - Nat Rev Drug Discov. 2004 Apr;3(4):318-29 – reference: 25457200 - J Hepatol. 2015 Mar;62(3):581-9 – reference: 2985616 - J Biol Stand. 1985 Jan;13(1):67-76 – reference: 11559036 - Chem Res Toxicol. 2001 Sep;14(9):1218-31 – reference: 19637986 - Expert Opin Drug Metab Toxicol. 2009 Oct;5(10):1159-74 – reference: 26626330 - Chem Biol Interact. 2016 Aug 5;255 :31-44 – reference: 16602092 - Am J Med Genet C Semin Med Genet. 2006 May 15;142C(2):104-12 – reference: 5963894 - Biochem Biophys Res Commun. 1966 Jun 13;23(5):696-701 – reference: 23428739 - Mol Genet Metab. 2013 Apr;108(4):203-5 – reference: 25963861 - Mol Genet Metab. 2015 Aug;115(4):174-9 – reference: 22678880 - Am J Med Genet A. 2012 Jul;158A(7):1641-6 – reference: 20421935 - PLoS Comput Biol. 2010 Apr;6(4):e1000756 – reference: 7726381 - Brain Dev. 1994 Nov;16 Suppl:46-57 – reference: 12757933 - Biochim Biophys Acta. 2003 May 20;1638(1):43-9 – reference: 21963082 - Mol Genet Metab. 2012 Jan;105(1):26-33 – reference: 2495260 - Isr J Med Sci. 1989 Feb;25(2):103-6 |
| SSID | ssj0011594 |
| Score | 2.2313743 |
| Snippet | Propionic acidemia (PA) is a disorder of intermediary metabolism with defects in the alpha or beta subunits of propionyl CoA carboxylase (PCCA and PCCB... Background: Propionic acidemia (PA) is a disorder of intermediary metabolism with defects in the alpha or beta subunits of propionyl CoA carboxylase (PCCA and... |
| SourceID | pubmedcentral proquest pubmed crossref elsevier |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 355 |
| SubjectTerms | Actins - analysis Amino Acids, Branched-Chain - metabolism Ammonia Ammonia - metabolism Carbon-Carbon Ligases - genetics Carbon-Carbon Ligases - metabolism Cells, Cultured Child Fibroblasts - drug effects Fibroblasts - metabolism Hemodynamic flow Hemodynamics Hepatocyte Hepatocytes - cytology Hepatocytes - drug effects Hepatocytes - enzymology Hepatocytes - metabolism Humans Isoleucine - pharmacology Liver - enzymology Liver - metabolism Liver - pathology Methylmalonyl-CoA Decarboxylase - genetics Methylmalonyl-CoA Decarboxylase - metabolism Mutation Organic acidemia Propionic acidemia Propionic Acidemia - metabolism Urea Urea - metabolism Valine - pharmacology |
| Title | Recapitulation of metabolic defects in a model of propionic acidemia using patient-derived primary hepatocytes |
| URI | https://dx.doi.org/10.1016/j.ymgme.2015.12.008 https://www.ncbi.nlm.nih.gov/pubmed/26740382 https://www.proquest.com/docview/1772833318 https://www.proquest.com/docview/1790942183 https://pubmed.ncbi.nlm.nih.gov/PMC4852394 |
| Volume | 117 |
| WOSCitedRecordID | wos000372683600158&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals 2021 customDbUrl: eissn: 1096-7206 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0011594 issn: 1096-7192 databaseCode: AIEXJ dateStart: 19980101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ba9swFBZZu7G-jK3dJbsUDcZeMhdb8vUxKy3dhTJYN_JmFNlpXRI5pE5ofl3_2o6uubGwPoyAMZasyD6fj86Rjr6D0AfCKM_SyPf6YI17YRlFHrhB1OMk5ZSwhHPF9vn7e3J-nvZ62Y9W687uhZkNEyHS29ts_F9FDddA2HLr7D3E7RqFC3AOQocjiB2O_yR4MATZuGpMWi69ft6AqCWbdVHq6I1KdJhOgqMinif1uFKZcBhX-WJZZ6qmEAzpqldAv2elJBTQ1BRXMIY1NZ83JgDRZoSyqXZlXubS8T_bvzdchaubHr5VMiPJcN7pHrlSCc2iNjuJoDM_XdFpdWmTNauI8KW7zmo7863j1myRmdEI4kVIl1HC4FZ5SZCtamm9xdPAkS7pXKp5fs3wTbVy3xgZ9CTF9dF8dDmS9KhBpKaB_XQxENrF_7Xx0UUt2oC461w1kstG8oDkarP5LkmiDNTqbvfLSe-rW8gCa1EFNthHssRXKsRwoy9_M442nZ_1GN4lo-jiKXpivBnc1Sh8hlql2EcHXQHoGM3xR6zii9XCzT569NmePT62WQYPkFiFK64H2MEVG7jiSmCGFVxluYMrtnDFCq54Da7YwBUvwfU5-nV6cnF85pkcIB6PgqTxEtYPCZeGKIvpgIfgb7OA93kQxDHhvN-PisAfgJ1d0ITEKeUxDSP1K0nEipK-QDuiFuUrhP2gHHBQS5LwSUYxMLBlU8mgxgpofRC3EbEvP-eGIF_maRnmWwTfRp_cTeaptlePrVRzY-Jq0zUHnG6_8b3FQA4Skqt6TJT19CYPwD9OKYWxeVudzM9C6Q210UuNG9dbEiehT1PSRskKolwFSUC_WiKqK0VEH6YRoVn4-n7v4A3aW3z1b9FOM5mW79BDPmuqm8khepD00kPzGf0BvDIB4g |
| linkProvider | Elsevier |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Recapitulation+of+metabolic+defects+in+a+model+of+propionic+acidemia+using+patient-derived+primary+hepatocytes&rft.jtitle=Molecular+genetics+and+metabolism&rft.au=Chapman%2C+Kimberly+A.&rft.au=Collado%2C+Maria+S.&rft.au=Figler%2C+Robert+A.&rft.au=Hoang%2C+Stephen+A.&rft.date=2016-03-01&rft.issn=1096-7192&rft.volume=117&rft.issue=3&rft.spage=355&rft.epage=362&rft_id=info:doi/10.1016%2Fj.ymgme.2015.12.008&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_ymgme_2015_12_008 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1096-7192&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1096-7192&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1096-7192&client=summon |